MONTREAL, Nov. 19, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of ...
Dr. Rudolph currently serves as Head of Global Medical Affairs and Cross-TA Medical Affairs at Boehringer Ingelheim, where she leads a global transformation to build a market-leading Medical Affairs ...
These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.
Scott, who chairs the Senate Committee on Aging, is pressing for tighter oversight and greater transparency in the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback